23 / 74 · 0:58 · Original AXON film
KPV
The burned-in captions and transcript carry the scientific claims and their limitations. The visuals are conceptual illustrations, not validated molecular models or experimental images. The video has no voice or audio. The full explanation is visible on screen; optional accessible captions are available in the player.
Read every result in its study context. A cell experiment, animal model, exploratory analysis and controlled human trial answer different questions.
Prepared 05 November 2026. Regulatory status is jurisdiction- and date-specific. No claim of specialist review or exhaustive evidence coverage.
Transcript
Where was it tested?
KPV is a three-amino-acid sequence studied in inflammation research. For skin claims, one crucial question is where the experiment happened: in patients, or in a laboratory model? [1]
Cell-culture experiment | 2025
A 2025 study exposed cultured skin cells to particulate pollution and tested KPV. Researchers reported changes in oxidative stress, inflammatory signaling, and cell survival. [1]
Human cells ≠ human clinical trial
They also used a three-dimensional skin model. Human-derived cells are still not the same as treating people with eczema, acne, or psoriasis. [1]
Clinical evidence remains a gap
FDA notes missing human exposure data for KPV drug products. Delivery, clinical benefit, and safety still need careful testing before laboratory findings can support a skin-treatment claim. [2]
Sources and context
These linked sources support the evidence distinctions in this short overview. This is not a systematic review, endorsement or treatment recommendation.
- Sung et al. (2025): KPV in pollution-exposed keratinocytes and a 3D skin model →Skin-cell and 3D-model findings, not a clinical dermatology trial.
- FDA peptide safety information: KPV →No human exposure data identified for KPV drug products.
